Erratum: Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients (Med Microbiol Immunol, 10.1007/s00430-010-0172-z);Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients

Medical Microbiology and Immunology

Volumn 200, Issue 1, 2011, Pages 39-49

  Reuter, Stefan ^a   Oette, Mark ^b   Wilhelm, Frank Clemens ^c   Beggel, Bastian ^d   Kaiser, Rolf ^c   Balduin, Melanie ^c   Schweitzer, Finja ^c   Verheyen, Jens ^c   Adams, Ortwin ^a   Lengauer, Thomas ^d   Fätkenheuer, Gerd ^e   Pfister, Herbert ^c   Häussinger, Dieter ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b Augustinerinnen Hospital   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Co infection; HBV; HCV; Occult infection; Resistance mutations

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA;

ADOLESCENT; AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; ETHNICITY; FEMALE; GERMANY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEROPREVALENCE; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

EID: 78751606323     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-010-0179-5     Document Type: Erratum

References (53)

1. R Weber CA Sabin N Friis-Moller, et al. 2006 Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study Arch Intern Med 166 1632 1641 10.1001/archinte.166.15.1632 16908797 (Pubitemid 44232373)
2. Stürmer M, Doerr HW, Gürtler L (2009) Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus. Med Microbiol Immunol 198(3):147-155
3. JK Rockstroh 2006 Influence of viral hepatitis on HIV infection J Hepatol 44 S25 S27 10.1016/j.jhep.2005.11.007 16338020 (Pubitemid 43053869)
4. M Hofer HI Joller-Jemelka PJ Grob, et al. 1998 Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study Eur J Clin Microbiol Infect Dis 17 6 13 1:STN:280:DyaK1c7ntFWhtQ%3D%3D 10.1007/BF01584356 9512175 (Pubitemid 28072282)
5. M Nunez P Rios M Perez-Olmeda, et al. 2002 Lack of 'occult' hepatitis B virus infection in HIV-infected patients AIDS 16 2099 2101 10.1097/00002030- 200210180-00024 12370518 (Pubitemid 35205282)
6. W Jilg E Sieger R Zachoval, et al. 1995 Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus J Hepatol 23 14 20 1:STN:280:DyaK287jvVyqsg%3D%3D 10.1016/0168-8278(95)80305-X 8530804
7. CL Thio DM Netski J Myung, et al. 2004 Changes in hepatitis B virus DNA levels with acute HIV infection Clin Infect Dis 38 1024 1029 10.1086/382534 15034837 (Pubitemid 38457213)
8. K Yamamoto M Horikita F Tsuda, et al. 1994 Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen J Virol 68 2671 2676 1:CAS:528:DyaK2cXitFGhsrg%3D 8139044
9. D Jeantet I Chemin B Mandrand, et al. 2004 Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays J Med Virol 73 508 515 1:CAS:528:DC%2BD2cXmtFylsLs%3D 10.1002/jmv.20119 15221893 (Pubitemid 38857199)
10. P Vivekanandan R Kannangai SC Ray, et al. 2008 Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples Clin Infect Dis 46 1227 1236 10.1086/529437 18444860 (Pubitemid 351589907)
11. P Filippini N Coppola R Pisapia, et al. 2007 Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients J Med Virol 79 1679 1685 10.1002/jmv.20992 17854026 (Pubitemid 47479886)
12. Raimondo G, Pollicino T, Romano L et al. (2010) A 2010 update on occult hepatitis B infection. Pathol Biol (Paris)
13. D Neau M Winnock AC Jouvencel, et al. 2005 Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003 Clin Infect Dis 40 750 753 10.1086/427882 15714424 (Pubitemid 40381353)
14. NJ Shire SD Rouster SD Stanford, et al. 2007 The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients J Acquir Immune Defic Syndr 44 309 314 10.1097/QAI.0b013e31802e29a9 17159656 (Pubitemid 46328348)
15. RV Lo III I Frank R Gross, et al. 2007 Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients J Acquir Immune Defic Syndr 44 315 320 10.1097/QAI.0b013e31802ea499 (Pubitemid 46328349)
16. M Dorrucci C Valdarchi B Suligoi, et al. 2004 The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy AIDS 18 2313 2318 10.1097/00002030-200411190-00012 15577544 (Pubitemid 39620224)
17. MB Klein RG Lalonde S Suissa 2003 The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy J Acquir Immune Defic Syndr 33 365 372 1:CAS:528:DC%2BD3sXnvFyjs7c%3D 12843748
18. A Sagir M Oette R Kaiser, et al. 2007 Trends of prevalence of primary HIV drug resistance in Germany J Antimicrob Chemother 60 843 848 1:CAS:528:DC%2BD2sXht1ygtbjF 10.1093/jac/dkm274 17715124 (Pubitemid 47434265)
19. MI Allen M Deslauriers CW Andrews, et al. 1998 Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group Hepatology 27 1670 1677 1:CAS:528:DyaK1cXjvVCrsrY%3D 10.1002/hep.510270628 9620341 (Pubitemid 28264693)
20. M Oette R Kaiser M Daumer, et al. 2004 Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany Eur J Med Res 9 273 278 1:CAS:528:DC%2BD2cXmvVWqtr0%3D 15257882
21. SC Hadler FN Judson PM O'Malley, et al. 1991 Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection J Infect Dis 163 454 459 1:STN:280:DyaK3M7ktVSjtA%3D%3D 1825315
22. M Puoti M Airoldi R Bruno, et al. 2002 Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects AIDS Rev 4 27 35 11998781 (Pubitemid 34464232)
23. EA Santos CF Yoshida VC Rolla, et al. 2003 Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1 Eur J Clin Microbiol Infect Dis 22 92 98 1:CAS:528:DC%2BD3sXhvVyqsL8%3D 12627282
24. MV Sucupira FC Mello EA Santos, et al. 2006 Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations Mem Inst Oswaldo Cruz 101 655 660 10.1590/S0074-02762006000600013 17072479
25. RT Gandhi A Wurcel B McGovern, et al. 2003 Low prevalence of ongoing hepatitis B viremia in HIV-positive individuals with isolated antibody to hepatitis B core antigen J Acquir Immune Defic Syndr 34 439 441 10.1097/00126334-200312010-00013 14615664 (Pubitemid 37444474)
26. D Neau M Winnock T Galperine, et al. 2004 Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients HIV Med 5 171 173 1:CAS:528:DC%2BD2cXlt1eru7s%3D 10.1111/j.1468-1293.2004.00206.x 15139983 (Pubitemid 38765284)
27. P Filippini N Coppola R Pisapia, et al. 2006 Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy AIDS 20 1253 1260 10.1097/01.aids.0000232232.41877.2a 16816553 (Pubitemid 44030373)
28. AA Wagner F Denis P Weinbreck, et al. 2004 Serological pattern 'anti-hepatitis B core alone' in HIV or hepatitis C virus-infected patients is not fully explained by hepatitis B surface antigen mutants AIDS 18 569 571 10.1097/00002030-200402200-00028 15090814 (Pubitemid 38365889)
29. K Azadmanesh M Mohraz A Aghakhani, et al. 2008 Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody Intervirology 51 270 274 1:CAS:528:DC%2BD1cXhsVaju7zF 10.1159/000160217 18841029
30. K Pogany HL Zaaijer JM Prins, et al. 2005 Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients AIDS Res Hum Retroviruses 21 922 926 1:CAS:528:DC%2BD2MXht1Oqt7nJ 10.1089/aid.2005.21.922 16386107 (Pubitemid 41785777)
31. RR Rai A Mathur D Mathur, et al. 2007 Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission Trop Gastroenterol 28 19 23 17896605
32. WH Sheng JH Kao PJ Chen, et al. 2007 Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy Clin Infect Dis 45 1221 1229 10.1086/522173 17918088 (Pubitemid 47580325)
33. NJ Shire SD Rouster N Rajicic, et al. 2004 Occult hepatitis B in HIV-infected patients J Acquir Immune Defic Syndr 36 869 875 10.1097/00126334-200407010-00015 15213572 (Pubitemid 38859354)
34. NM Araujo M Branco-Vieira AC Silva, et al. 2008 Occult hepatitis B virus infection in HIV-infected patients: Evaluation of biochemical, virological and molecular parameters Hepatol Res 38 1194 1203 1:CAS:528:DC%2BD1MXks1WgsQ%3D%3D 18624719
35. G Nebbia A Garcia-Diaz U Ayliffe, et al. 2007 Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons J Med Virol 79 1464 1471 1:CAS:528:DC%2BD2sXhtVygu7nK 10.1002/jmv.20954 17705185 (Pubitemid 47328734)
36. AL French E Operskalski M Peters, et al. 2007 Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women J Infect Dis 195 1437 1442 1:CAS:528:DC%2BD2sXmtFKhurc%3D 10.1086/515578 17436223 (Pubitemid 46717461)
37. L Piroth C Binquet M Vergne, et al. 2002 The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients J Hepatol 36 681 686 1:CAS:528:DC%2BD38Xjtl2ksb0%3D 10.1016/S0168-8278(02)00019-3 11983452 (Pubitemid 34499406)
38. G Greub B Ledergerber M Battegay, et al. 2000 Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study Lancet 356 1800 1805 1:STN:280:DC%2BD3M%2FmtlOltw%3D%3D 10.1016/S0140-6736(00)03232-3 11117912
39. G Morsica S Bagaglio S Ghezzi, et al. 2007 Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: possible protective effect of infecting HCV genotype on HIV disease progression J Clin Virol 39 82 86 10.1016/j.jcv.2007.03.007 17434339 (Pubitemid 46784032)
40. X Zhang J Xu H Peng, et al. 2008 HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naive to ART PLoS One 3 e3992 10.1371/journal.pone.0003992 19098990
41. B Ramos M Nunez L Martin-Carbonero, et al. 2007 Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients J Acquir Immune Defic Syndr 44 557 561 10.1097/QAI.0b013e3180314b46 17224847 (Pubitemid 46594899)
42. M Lindh AS Andersson A Gusdal 1997 Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method J Infect Dis 175 1285 1293 1:CAS:528:DyaK2sXjslynu7s%3D 10.1086/516458 9180165
43. A Erhardt D Blondin K Hauck, et al. 2005 Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D Gut 54 1009 1013 1:CAS:528:DC%2BD2MXmsFKqtrg%3D 10.1136/gut.2004.060327 15951551 (Pubitemid 40873918)
44. M Laguno M Larrousse JL Blanco, et al. 2008 Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients AIDS Res Hum Retroviruses 24 547 553 1:CAS:528:DC%2BD1cXltFehtr0%3D 10.1089/aid.2007.9994 18393687 (Pubitemid 351571046)
45. G Morsica F Ancarani S Bagaglio, et al. 2009 Occult hepatitis B virus infection in a Cohort of HIV-positive patients: Correlation with hepatitis C virus coinfection, virological and immunological features Infection 37 445 449 1:STN:280:DC%2BD1MnptVWqtw%3D%3D 10.1007/s15010-008-8194-9 19669092
46. R Palacios R Mata A Hidalgo, et al. 2008 Very low prevalence and no clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: the BHOI study HIV Clin Trials 9 337 340 1:STN:280:DC%2BD1cjhtFequw%3D%3D 10.1310/hct0905-337 18977722
47. L Piroth ME Lafon C Binquet, et al. 2008 Occult hepatitis B in HIV-HCV coinfected patients Scand J Infect Dis 40 835 839 1:CAS:528:DC%2BD1cXhtFeitLrJ 10.1080/00365540701787818 18609222 (Pubitemid 351997678)
48. J Quarleri F Moretti MB Bouzas, et al. 2007 Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B AIDS Res Hum Retroviruses 23 525 531 1:CAS:528:DC%2BD2sXksFSjsLs%3D 10.1089/aid.2006.0172 17506609 (Pubitemid 46700885)
49. S Ramia J Mokhbat F Ramlawi, et al. 2008 Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen Int J STD AIDS 19 197 199 1:STN:280: DC%2BD1c3jvVWnuw%3D%3D 10.1258/ijsa.2007.007200 18397562 (Pubitemid 351738799)
50. M Rodriguez-Torres J Gonzalez-Garcia N Brau, et al. 2007 Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? J Med Virol 79 694 700 1:STN:280:DC%2BD2szjtVarsA%3D%3D 10.1002/jmv.20836 17457912 (Pubitemid 46709363)
51. Taylor L, Gholam P, Delong A et al (2008) Occult hepatitis B virus (HBV) and hepatitis C virus (HCV) viremia in women with and at-risk for HIV/AIDS. In: 17th International AIDS conference. Mexico City, Mexico
52. R Torres-Baranda BE Bastidas-Ramirez M Maldonado-Gonzalez, et al. 2006 Occult hepatitis B in Mexican patients with HIV, an analysis using nested polymerase chain reaction Ann Hepatol 5 34 40 1:CAS:528:DC%2BD28XjtlWlur8%3D 16531963
53. JI Tsui AL French EC Seaberg, et al. 2007 Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women Clin Infect Dis 45 736 740 1:CAS:528:DC%2BD2sXhtFahtrrK 10.1086/520989 17712758 (Pubitemid 47378888)